Comparative effectiveness of first‐line radiofrequency ablation versus surgical resection and transplantation for patients with early hepatocellular carcinoma
OC Kutlu, JA Chan, TA Aloia, YS Chun, AO Kaseb… - Cancer, 2017 - Wiley Online Library
BACKGROUND Significant controversy exists as to which treatment modality is most
effective for small, solitary hepatocellular carcinomas (HCCs): radiofrequency ablation …
effective for small, solitary hepatocellular carcinomas (HCCs): radiofrequency ablation …
Systemic therapy and sequencing options in advanced hepatocellular carcinoma: a systematic review and network meta-analysis
Importance The treatment landscape for advanced hepatocellular carcinoma (HCC) has
recently changed and become relatively confusing. Head-to-head comparisons between …
recently changed and become relatively confusing. Head-to-head comparisons between …
[HTML][HTML] Identifying optimal therapies in patients with advanced hepatocellular carcinoma: A systematic review and network meta-analysis
Z Yang, Y Tong, L Yang, X He, G Bao… - Translational …, 2022 - ncbi.nlm.nih.gov
Background Recently, increasing literature has been reported on optimal therapies in
patients with advanced hepatocellular carcinoma (HCC) and many therapeutic modalities …
patients with advanced hepatocellular carcinoma (HCC) and many therapeutic modalities …
Comparison of DEB-TACE and cTACE for the initial treatment of unresectable hepatocellular carcinoma beyond up-to-seven criteria: a single-center propensity score …
Q Shi, J Liu, T Li, C Zhou, Y Wang, S Huang… - Clinics and research in …, 2022 - Elsevier
Purpose To evaluate clinical outcomes of drug-eluting beads transarterial
chemoembolization (DEB-TACE) with CalliSpheres microspheres and conventional TACE …
chemoembolization (DEB-TACE) with CalliSpheres microspheres and conventional TACE …
Laparoscopic liver resection is superior to radiofrequency ablation for small hepatocellular carcinoma: a systematic review and meta-analysis of propensity score …
W Chen, X Lin, Z Wu, W Pan, Q Ke, Y Chen - Hepatology International, 2024 - Springer
Background The approach in small hepatocellular carcinoma (HCC) is controversial, no
prospective randomized trials to compare ablative or surgical approaches. We compared the …
prospective randomized trials to compare ablative or surgical approaches. We compared the …
Comparison of liver resection and radiofrequency ablation in long-term survival among patients with early-stage hepatocellular carcinoma: a meta-analysis of …
L Hu, J Lin, A Wang, X Shi, Y Qiao - World Journal of Surgical Oncology, 2024 - Springer
Background Whether radiofrequency ablation (RFA) and liver resection (LR) are
comparable treatments for early-stage hepatocellular carcinoma (HCC) is controversial. We …
comparable treatments for early-stage hepatocellular carcinoma (HCC) is controversial. We …
[HTML][HTML] Management of “very early” hepatocellular carcinoma on cirrhotic patients
G Sapisochin, EF de Sevilla, J Echeverri… - World Journal of …, 2014 - ncbi.nlm.nih.gov
Due to the advances in screening of cirrhotic patients, hepatocellular carcinoma (HCC) is
being diagnosed in earlier stages. For this reason the number of patients diagnosed of very …
being diagnosed in earlier stages. For this reason the number of patients diagnosed of very …
Treatment of intermediate/advanced hepatocellular carcinoma in the clinic: how can outcomes be improved?
R Lencioni, XP Chen, L Dagher, AP Venook - The oncologist, 2010 - academic.oup.com
Hepatocellular carcinoma (HCC) is a complex condition associated with a poor prognosis.
Treatment outcomes are affected by multiple variables, including liver function, performance …
Treatment outcomes are affected by multiple variables, including liver function, performance …
[HTML][HTML] Therapeutic approaches in intermediate-stage hepatocellular carcinoma (HCC): a novel insight of adjuvant transarterial chemoembolization (TACE)
P Fernández-Palanca, JL Mauriz - Chinese Clinical Oncology, 2023 - cco.amegroups.org
Prognosis of patients with hepatocellular carcinoma (HCC) is associated to tumor burden,
cancer-related characteristics and symptoms, while remains highly dependent on the stage …
cancer-related characteristics and symptoms, while remains highly dependent on the stage …
Treatment strategy for intermediate-stage hepatocellular carcinoma: transarterial chemoembolization, systemic therapy, and conversion therapy
T Hatanaka, Y Yata, A Naganuma, S Kakizaki - Cancers, 2023 - mdpi.com
Simple Summary Systemic therapy for advanced-stage hepatocellular carcinoma (HCC) is
undergoing major changes owing to the advancements made in molecular-targeted …
undergoing major changes owing to the advancements made in molecular-targeted …